Check out the best TED Talks below to understand the growing importance of stem cells within regenerative medicine.
In this article:
Hematopoietic Stem Cells (HSCs)
What Is Multiple Sclerosis? | FAQs
Learn more about multiple sclerosis treatment and how stem cells can help in treating this condition here.
in this article:
- What Is Multiple Sclerosis?
- How Do You Treat Multiple Sclerosis?
- How Much Does It Cost for MS Treatment?
- What Is the Role of Stem Cells in Multiple Sclerosis Treatment?
- Where To Go For MS Stem Cell Treatment
- What Are the Factors to Consider That Place a Person at a Higher Risk for MS?
- Multiple Sclerosis Research
AABB Releases New Resources and Initiatives For its Certified Advanced Biotherapies Professional (CABP) Program
May 1, 2024, Bethesda, MD – The Association for the Advancement of Blood & Biotherapies (AABB) is pleased to announce several new offerings as part of its Certified Advanced Biotherapies Professional (CABP) credentialing program. These updates, released to make the CABP program more accessible to biotherapies professionals and organizations, include: [Read more…]
The Present and Future Trajectory of the Cord Blood & Tissue Banking Market
Umbilical cord blood (UCB) has been an accepted source of hematopoietic stem cells (HSC) for transplantation for more than 30 years. Umbilical cord-derived stem cells are the youngest cells available for transfusion and yet their uptake lags behind bone marrow and peripheral blood-derived HSCs. Decreased engraftment rates and the low cell dose available for transplantation are limitations that are preventing umbilical cord blood-derived cells from reaching their full potential. While a handful of companies are now developing cord blood and tissue-derived cell therapeutics, it will likely take several years for these products to reach commercialization. [Read more…]
First Patient Dosed with Gamida Cell’s Expanded Cord Blood Cell Therapy, Omisirge™
Omisirge is the world’s 1st U.S. FDA approved product that is a expanded umbilical cord blood cell therapy.
It is also the only allogeneic stem cell therapy approved by the U.S. FDA on the basis of a global randomized Phase 3 trial.
Rapid onboarding of transplant centers and significant payer coverage demonstrate strong launch progress.
Boston, MA, September 27, 2023 –– Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, announced that the first patient has received a stem cell transplant with Omisirge (omidubicel-onlv). [Read more…]
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 28
- Next Page »